GEAN — Genetic Analysis As Cashflow Statement
0.000.00%
Last trade - 00:00
- NOK21.39m
- NOK10.55m
- NOK14.15m
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | — | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -6.94 | -22.1 | -29 | -28.3 | -23.8 |
Depreciation | |||||
Non-Cash Items | 5.11 | 3.3 | -3.15 | 2.73 | -0.89 |
Other Non-Cash Items | |||||
Changes in Working Capital | -7.02 | 6.08 | -0.017 | 1.26 | 1.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -6.36 | -6.56 | -27.6 | -19.5 | -17.2 |
Capital Expenditures | -8.23 | -5.18 | -1.95 | -0.227 | -0.643 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 0.018 | — | -0.5 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -8.23 | -5.18 | -1.94 | -0.227 | -1.14 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.64 | 31.9 | 52.2 | -1.8 | 9.34 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -16.2 | 20.2 | 22.6 | -21.5 | -9.03 |